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Letters
Acute Cervical Lymphadenopathy
To the Editor: Acute cervical lymphadenopathy
has not been reported as a symptom of Myco-
bacterium genavense infection. In June 1994, a 32-
year-old injecting drug user, who had been
monitored since 1987 for human immunodeficiency
virus (HIV) infection at the outpatient clinic of the
Infectious Disease Institute, Perugia, Italy, was
admitted to a hospital with fever (39°C) and pro-
gressive swelling over the submandibular region
and neck. In addition to being febrile, upon physi-
cal
examination the patient had tender left
submandibular and cervical lymphadenopathy ap-
proximately 3 cm in diameter, with redness and
edema of the overlying skin. The CD4+ lymphocyte
count was 0.01 x 109/L. A specimen obtained by
needle aspiration of the submandibular lymph node
contained numerous acid-fast bacilli, and the
patient was treated with isoniazid, rifampin,
ethambutol, and amikacin for presumed Mycobac-
terium tuberculosis with a good response; however,
10 days later, the patient’s submandibular pain re-
curred along with abdominal pain and bowel
irregularities. Gastroscopy showed superficial
duodenal erosions, and acid-fast bacilli were visu-
alized by microscopy. Shortly thereafter, pain and
swelling of the patient’s right ankle developed, and
small lesions were noted on the dorsum of the right
foot. Clarithromycin was substituted for the
amikacin for suspected without a clear response,
and a course of steroids was initiated with clinical
improvement. Symptoms recurred when the ste-
roids were tapered. Ciprofloxacin was substituted
for isoniazid, and amikacin was readministered.
Material from a repeat needle aspiration of the sub-
mandibular node 1 month later also showed
acid-fast bacilli by microscopy.
Cultures of the initial submandibular aspirate
demonstrated poor growth in Bactec 13A broth and
did not grow on solid media. The specimen was sent
to a reference laboratory where acid-fast bacilli were
successfully isolated 10 weeks later in Middlebrook
agar containing mycobactin J. These acid-fast ba-
cilli were subsequently identified as M. genavense
by high-pressure liquid chromatography and nucleic
acid sequencing of the 16S rRNA. By this point, the
patient had improved on a regimen of isoniazid,
pyrazinamide, clofazimine, and amikacin for pre-
sumed M. genavense infection, and this regimen was
continued. The patient died 19 months later; cul-
tures for mycobacteria were persistently negative
even when antimycobacterial drugs were discon-
tinued 16 months after the initial episode.
M. genavense is a novel mycobacterial species
that causes serious disseminated infections with
massive involvement of the small intestine, spleen,
liver, and abdominal lymph nodes in profoundly im-
munocompromised persons. Cultures with Bactec
13A vials containing radiometric liquid medium are
generally positive but subcultures on solid media
are unsuccessful (1). Lowering the pH of medium
to six enhances its growth (1), while adding myco-
bactin J to Middlebrook 7H11 (2) solid media can
help in the isolation. The suppression of growth of
M. genavense by NAP can cause confusion with the
M. tuberculosis complex; however, M. genavense can
be easily distinguished by its slow growth and its
dysgonic nature. At present, the way to identify M.
genavense is by 16S rRNA sequencing (3). High-
pressure liquid chromatography can be used (4).
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